Cost-effectiveness analysis of renal replacement therapy strategies in Guangzhou city, southern China

Objectives This study aims to assess the cost-effectiveness of three renal replacement therapy (RRT) modalities as well as proposed changes of scheduled policies in RRT composition in Guangzhou city.Methods From a payer perspective, we designed Markov model-based cost-effectiveness analyses to compa...

Full description

Bibliographic Details
Main Authors: Meixia Liao, Pusheng Wang, Yongguang Liu
Format: Article
Language:English
Published: BMJ Publishing Group 2021-02-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/2/e039653.full
id doaj-0977fa5a54be4919bee832bfdcd68448
record_format Article
spelling doaj-0977fa5a54be4919bee832bfdcd684482021-06-25T13:30:42ZengBMJ Publishing GroupBMJ Open2044-60552021-02-0111210.1136/bmjopen-2020-039653Cost-effectiveness analysis of renal replacement therapy strategies in Guangzhou city, southern ChinaMeixia Liao0Pusheng Wang1Yongguang Liu22 Institute for Hospital Management, Tsinghua University, Shenzhen, China1 Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, China3 Organ Transplantation Center, Zhujiang Hospital, Guangzhou, ChinaObjectives This study aims to assess the cost-effectiveness of three renal replacement therapy (RRT) modalities as well as proposed changes of scheduled policies in RRT composition in Guangzhou city.Methods From a payer perspective, we designed Markov model-based cost-effectiveness analyses to compare the cost-effectiveness of three RRT modalities and four different scheduled policies to RRT modalities in Guangzhou over three time horizons (5, 10 and 15 years). The current situation (scenario 1: haemodialysis (HD), 73%; peritoneal dialysis (PD), 14%; kidney transplantation (TX), 13%) was compared with three different scenarios: an increased proportion of incident RRT patients on PD (scenario 2: HD, 47%; PD, 40%; TX, 13%); on TX (scenario 3: HD, 52%; PD, 14%; TX, 34%); on both PD and TX (Scenario 4: HD, 26%; PD, 40%; TX, 34%).Results Over 5-year time horizon, HD was dominated by PD. At a willingness-to-pay (WTP) threshold of US$44 300, TX was cost-effective compared with PD with an incremental cost-effectiveness ratio of US$35 518 per quality-adjusted life year (QALY) gained. The scenario 2 held a dominant position over the scenario 1, with a net saving of US$ 5.92 million and an additional gain of 6.24 QALYs. The scenarios 3 and 4 were cost-effective compared with scenario 1 at a WTP threshold of US$44 300. The above results were consistent across the three time horizons.Conclusions TX is the most cost-effective RRT modality, followed in order by PD and HD. The strategy with an increased proportion of incident patients on PD and TX is cost-effective compared with the current practice pattern at the given WTP threshold. The planning for RRT service delivery should incorporate efforts to increase the utilisation of PD and TX in China.https://bmjopen.bmj.com/content/11/2/e039653.full
collection DOAJ
language English
format Article
sources DOAJ
author Meixia Liao
Pusheng Wang
Yongguang Liu
spellingShingle Meixia Liao
Pusheng Wang
Yongguang Liu
Cost-effectiveness analysis of renal replacement therapy strategies in Guangzhou city, southern China
BMJ Open
author_facet Meixia Liao
Pusheng Wang
Yongguang Liu
author_sort Meixia Liao
title Cost-effectiveness analysis of renal replacement therapy strategies in Guangzhou city, southern China
title_short Cost-effectiveness analysis of renal replacement therapy strategies in Guangzhou city, southern China
title_full Cost-effectiveness analysis of renal replacement therapy strategies in Guangzhou city, southern China
title_fullStr Cost-effectiveness analysis of renal replacement therapy strategies in Guangzhou city, southern China
title_full_unstemmed Cost-effectiveness analysis of renal replacement therapy strategies in Guangzhou city, southern China
title_sort cost-effectiveness analysis of renal replacement therapy strategies in guangzhou city, southern china
publisher BMJ Publishing Group
series BMJ Open
issn 2044-6055
publishDate 2021-02-01
description Objectives This study aims to assess the cost-effectiveness of three renal replacement therapy (RRT) modalities as well as proposed changes of scheduled policies in RRT composition in Guangzhou city.Methods From a payer perspective, we designed Markov model-based cost-effectiveness analyses to compare the cost-effectiveness of three RRT modalities and four different scheduled policies to RRT modalities in Guangzhou over three time horizons (5, 10 and 15 years). The current situation (scenario 1: haemodialysis (HD), 73%; peritoneal dialysis (PD), 14%; kidney transplantation (TX), 13%) was compared with three different scenarios: an increased proportion of incident RRT patients on PD (scenario 2: HD, 47%; PD, 40%; TX, 13%); on TX (scenario 3: HD, 52%; PD, 14%; TX, 34%); on both PD and TX (Scenario 4: HD, 26%; PD, 40%; TX, 34%).Results Over 5-year time horizon, HD was dominated by PD. At a willingness-to-pay (WTP) threshold of US$44 300, TX was cost-effective compared with PD with an incremental cost-effectiveness ratio of US$35 518 per quality-adjusted life year (QALY) gained. The scenario 2 held a dominant position over the scenario 1, with a net saving of US$ 5.92 million and an additional gain of 6.24 QALYs. The scenarios 3 and 4 were cost-effective compared with scenario 1 at a WTP threshold of US$44 300. The above results were consistent across the three time horizons.Conclusions TX is the most cost-effective RRT modality, followed in order by PD and HD. The strategy with an increased proportion of incident patients on PD and TX is cost-effective compared with the current practice pattern at the given WTP threshold. The planning for RRT service delivery should incorporate efforts to increase the utilisation of PD and TX in China.
url https://bmjopen.bmj.com/content/11/2/e039653.full
work_keys_str_mv AT meixialiao costeffectivenessanalysisofrenalreplacementtherapystrategiesinguangzhoucitysouthernchina
AT pushengwang costeffectivenessanalysisofrenalreplacementtherapystrategiesinguangzhoucitysouthernchina
AT yongguangliu costeffectivenessanalysisofrenalreplacementtherapystrategiesinguangzhoucitysouthernchina
_version_ 1721359641123749888